Related Experiment Videos
Hepatic aluminum accumulation in children on total parenteral nutrition
Insights
Children on long-term total parenteral nutrition (TPN) with casein hydrolysate showed liver damage. Elevated aluminum levels in the liver suggest a potential role in TPN-associated liver dysfunction.
Area of Science:
- Hepatology
- Pediatric Gastroenterology
- Clinical Nutrition
Background:
- Long-term total parenteral nutrition (TPN) is a critical intervention for children with intestinal failure.
- Casein hydrolysate is used as a protein source in TPN formulations.
- Cholestasis and abnormal liver function tests are known complications of TPN.
Purpose of the Study:
- To investigate the histopathological changes in the livers of children receiving long-term TPN with casein hydrolysate.
- To determine the hepatic aluminum content in these patients.
- To explore the potential role of aluminum deposition in TPN-associated liver dysfunction.
Main Methods:
- Percutaneous liver biopsies were performed on five children with cholestasis and abnormal liver function tests during TPN.
- Histopathological examination of liver tissue was conducted.
- Hepatic aluminum content was measured in all biopsy samples.
Main Results:
- All five children exhibited moderate to severe histopathological changes in their liver biopsies.
- Markedly elevated hepatic aluminum content was detected in all cases.
- No definitive conclusions on aluminum hepatotoxicity were drawn, but its association with other tissue pathology was noted.
Conclusions:
- TPN with casein hydrolysate may be associated with significant liver histopathological changes in children.
- Elevated hepatic aluminum levels are consistently found in these patients.
- Aluminum deposition should be considered as a potential contributing factor or exacerbating agent in TPN-induced liver injury.
Abstract:
Five children receiving long-term total parenteral nutrition (TPN) containing casein hydrolysate as the protein source underwent percutaneous liver biopsies because of the development of cholestasis and abnormal liver function tests. All five demonstrated moderate to severe histopathologic changes. In addition, hepatic aluminum content was determined to be markedly elevated in all cases. Although the hepatotoxicity of aluminum is as yet undetermined, deposition of other metals has been associated with liver damage, and aluminum has been associated with pathology in other tissues. Thus, the possibility that aluminum deposition may play a role in the pathogenesis or exacerbate the course of liver dysfunction associated with TPN should be considered.